Medtronic, Inc. (NYSE:MDT) today announced worldwide introduction of the new and unique Medtronic CG Future(R) COMPOSITE Annuloplasty Ring used by heart surgeons to repair - rather than replace - a mitral valve that is narrowed or leaking. The new CG Future COMPOSITE Ring is the industry’s first annuloplasty product providing both semi-rigid posterior remodeling and fully flexible anterior support, thereby allowing physiologic movement throughout the cardiac cycle.
